THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (ABCC7)

ABC Proteins: from Bacteria to Man

Volumn , Issue , 2003, Pages 589-618

  Hanrahan, John W ^a   Gentzsch, Martina ^b   Riordan, John R ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346636602     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012352551-2/50030-5     Document Type: Chapter

References (221)

1. L. Aguilar-Bryan, J.P. Clement J.P.t., G. Gonzalez, K. Kunjilwar, A. Babenko and J. Bryan (1998) Toward understanding the assembly and structure of KATP channels. Physiol. Rev. 78(1), 227-245.
2. M.H. Akabas (2000) Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel. J. Biol. Chem. 275(6), 3729-3732.
3. M.H. Akabas, C. Kaufmann, T.A. Cook and P. Archdeacon (1994) Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269(21), 14865-14868.
4. A.A. Aleksandrov and J.R. Riordan (1998) Regulation of CFTR ion channel gating by MgATP. FEBS Lett. 431(1), 97-101.
5. A.A. Aleksandrov, X. Chang, L. Aleksandrov and J.R. Riordan (2000) The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating. J. Physiol. 528(Pt 2), 259-265.
6. L. Aleksandrov, A. Mengos, X. Chang, A. Aleksandrov and J.R. Riordan (2001) Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 276(16), 12918-12923.
7. L. Aleksandrov, A.A. Aleksandrov, X.-B. Chang and J.R. Riordan (2002) The first nucleotide binding domain of CFTR is a site of stable nucleotide binding domain of CFTR is a site of stable nucleotide interaction whereas the second is a site of rapid turnover. J. Biol. Chem. 3 15419-15425.
8. M.P. Anderson, H.A. Berger, D.P. Rich, R.J. Gregory, A.E. Smith and M.J. Welsh (1991) Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 67 775-784.
9. M.P. Anderson, R.J. Gregory, S. Thompson, D.W. Souza, S. Paul, R.C. Mulligan, A.E. Smith and M.J. Welsh (1991) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253 202-205.
10. M.P. Anderson, D.P. Rich, R.J. Gregory, A.E. Smith and M.J. Welsh (1991) Generation of cAMP-activated chloride currents by expression of CFTR. Science 251 679-682.
11. A.L. Arsenault, V. Ling and N. Kartner (1988) Altered plasma membrane ultrastructure in multidrug-resistant cells. Biochim. Biophys. Acta. 938(2), 315-321.
12. R.B. Bajnath, J.A. Groot, H.R. De Jonge, M. Kansen and J. Bijman (1993) Synergistic activation of non-rectifying small-conductance chloride channels by forskolin and phorbol esters in cell-attached patches of the human colon carcinoma cell line HT-29cl.19A. Pflugers Arch. 425(1–2), 100-108.
13. S.I. Bannykh, G.I. Bannykh, K.N. Fish, B.D. Moyer, J.R. Riordan and W.E. Balch (2000) Traffic pattern of cystic fibrosis transmembrane regulator through the early exocytic pathway. Traffic 1(11), 852-870.
14. T. Baukrowitz, T.C. Hwang, A.C. Nairn and D.C. Gadsby (1994) Coupling of CFTR Cl− channel gating to an ATP hydrolysis cycle. Neuron 12(3), 473-482.
15. C.E. Bear and E.F. Reyes (1992) cAMP-activated chloride conductance in the colonic cell line, Caco-2. Am. J. Physiol. 262(1 Pt 1), C251-C256.
16. C.E. Bear, F. Duguay, A.L. Naismith, N. Kartner, J.W. Hanrahan and J.R. Riordan (1991) Cl− channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J. Biol. Chem. 266(29), 19142-19145.
17. C.E. Bear, C. Li, N. Kartner, R.J. Bridges, T.J. Jensen, M. Ramjeesingh and J.R. Riordan (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68 809-818.
18. F. Becq, T.J. Jensen, X.B. Chang, A. Savoia, J.M. Rommens, L.C. Tsui, M. Buchwald, J.R. Riordan and J.W. Hanrahan (1994) Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc. Natl Acad. Sci. USA 91(19), 9160-9164.
19. A.L. Berger and M.J. Welsh (2000) Differences between cystic fibrosis transmembrane conductance regulator and HisP in the interaction with the adenine ring of ATP. J. Biol. Chem. 275(38), 29407-29412.
20. A.L. Berger, M. Ikuma, J.F. Hunt, P.J. Thomas and M.J. Welsh (2002) Mutations that change the position of the putative gammaphosphate linker in the nucleotide binding domains of CFTR alter channel gating. J. Biol. Chem. 277(3), 2125-2131.
21. H.A. Berger, M.P. Anderson, R.J. Gregory, S. Thompson, P.W. Howard, R.R. Maurer, R. Mulligan, A.E. Smith and M.J. Welsh (1991) Identification and regulation of the CFTR-generated chloride channel. J. Clin. Invest. 88 1422-1431.
22. J. Borchardt, J. Kole and J. Cohn (1996) Phosphorylation of CFTR Ser-737 by protein kinase A. Pediatr. Pulm. (Suppl. 13), 212. (Abstract)
23. R.C. Boucher (1994) Human airway ion transport. Part two. Am. J. Respir. Crit. Care Med. 150(2), 581-593.
24. I. Bronsveld, F. Mekus, J. Bijman, M. Ballmann, H.R. de Jonge, U. Laabs, et al. (2001) Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J. Clin. Invest. 108(11), 1705-1715.
25. A. Brooks-Wilson, M. Marcil, S.M. Clee, L.H. Zhang, K. Roomp, M. van Dam, et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22(4), 336-345.
26. C.R. Brown, L.Q. Hong-Brown, J. Biwersi, A.S. Verkman and W.J. Welch (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperon 1(2), 117-125.
27. B. Button, L. Reuss and G.A. Altenberg (2001) PCK-mediated stimulation of amphibian CFTR depends on a single phosphorylation consensus site: insertion of this site confers PKC sensitivity to human CFTR. J. Gen. Physiol. 117(5), 457-468.
28. T.P. Carroll, M.M. Morales, S.B. Fulmer, S.S. Allen, T.R. Flotte, G.R. Cutting and W.B. Guggino (1995) Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 270(20), 11941-11946.
29. M.R. Carson and M.J. Welsh (1993) 5′-adenylylimidodiphosphate does not activate CFTR chloride channels in cell-free patches of membrane. Am. J. Physiol. 265(1 Pt 1), L27-L32.
30. M.R. Carson, S.M. Travis and M.J. Welsh (1995) The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. J. Biol. Chem. 270(4), 1711-1717.
31. E.A. Cartier, L.R. Conti, C.A. Vandenberg and S.L. Shyng (2001) Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc. Natl Acad. Sci. USA 98(5), 2882-2887.
32. W.A. Catterall (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26(1), 13-25.
33. G. Champigny, B. Verrier, C. Gerard, J. Mauchamp and M. Lazdunski (1990) Small conductance chloride channels in the apical membrane of thyroid cells. FEBS Lett. 259(2), 263-268.
34. X.-B. Chang, J.A. Tabcharani, Y.-X. Hou, T.J. Jensen, N. Kartner, N. Alon, J.W. Hanrahan and J.R. Riordan (1993) Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all ten PKA consensus phosphorylation sites. J. Biol. Chem. 268(15), 11304-11311.
35. X.-B. Chang, Y.-X. Hou, T. Jensen and J.R. Riordan (1994) Mapping of the cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J. Biol. Chem. 269(28), 18572-18575.
36. X.-B. Chang, L. Cui, Y. Hou, T.J. Jensen, A.A. Aleksandrov, A. Mengos and J.R. Riordan (1999) Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol. Cell 4(1), 137-142.
37. V. Chappe, D.A.R. Hinkson, X.-B. Chang, J.R. Riordan and J.W. Hanrahan (2002) Phosphorylation of protein kinase C consensus sites in NBD1 and the R domain control CFTR channel activation by PKA. J. Physiol. (in press)
38. J.-H. Chen and J.R. Riordan (2002) Chemical cross-linking reveals different CFTR associations when the protein is heterologously and endogenously expressed. Arch. Biochem. Biophys. (submitted)
39. J.-H. Chen, X.-B. Chang, A.A. Aleksandrov and J.R. Riordan (2002) CFTR is a monomer: biochemical and functional evidence. J. Membrane Biol. (on line DOI: 10.1007/500232-001-0174-2 (07/10/02)
40. J.M. Chen, C. Cutler, C. Jacques, G. Boeuf, E. Denamur, G. Lecointre, B. Mercier, G. Cramb and C. Ferec (2001) A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models. Mol. Biol. Evol. 18(9), 1771-1788.
41. J. Cheng, B.D. Moyer, M. Milewski, J. Loffing, M. Ikeda, J.E. Mickle, G.R. Cutting, M. Li, R.A. Stanton and W.B. Gugino (2002) A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J. Biol. Chem. 277(5), 3520-3529.
42. S.H. Cheng, R.J. Gregory, J. Marshall, S. Paul, D.W. Souza, G.A. White, C.R. O'Riordan and A.E. Smith (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 827-834.
43. S.H. Cheng, D.P. Rich, J. Marshall, R.J. Gregory, M.J. Welsh and A.E. Smith (1991) Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66 1027-1036.
44. M. Cheung and M.H. Akabas (1997) Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. J. Gen. Physiol. 109(3), 289-299.
45. J.F. Cotten and M.J. Welsh (1999) Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge. J. Biol. Chem. 274(9), 5429-5435.
46. A.W. Cuthbert, J. Halstead, R. Ratcliff, W.H. Colledge and M.J. Evans (1995) The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J. Physiol. 482(Pt 2), 449-454.
47. D. Dahan, T. Zhu, A. Evagleidis and J.W. Hanrahan (1999) CFTR-protein phosphatase 2C (PP2C) association is independent of the carboxyl terminus PDZ binding motif. FASEB J. 13 A71. (Abstract)
48. D.C. Dawson, S.S. Smith and M.K. Mansoura (1999) CFTR: mechanism of anion conduction. Physiol. Rev. 79(1 Suppl), S47-S75.
49. M.C. Dechecchi, R. Rolfini, A. Tamanini, C. Gamberi, G. Berton and G. Cabrini (1992) Effect of modulation of protein kinase C on the cAMP-dependent chloride conductance in T84 cells. FEBS Lett. 311(1), 25-28.
50. R.G. Deeley and S.P. Cole (1997) Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol. 8(3), 193-204.
51. G.M. Denning, M.P. Anderson, J.F. Amara, J. Marshall, A.E. Smith and M.J. Welsh (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358(6389), 761-764.
52. P.H. Dixon, N. Weerasekera, K.J. Linton, O. Donaldson, J. Chambers, E. Egginton, et al. (2000) Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum. Mol. Genet. 9(8), 1209-1217.
53. R.L. Dormer, R. Derand, C.M. McNeilly, Y. Mettey, L. Bulteau-Pignoux, T. Metaye, et al. (2001) Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J. Cell Sci. 114(Pt 22), 4073-4081.
54. D.A. Doyle, J. Morais Cabral, R.A. Pfuetzner, A. Kuo, J.M. Gulbis, S.L. Cohen, B.T. Chait and R. MacKinnon (1998) The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280(5360), 69-77.
55. M.L. Drumm, D.J. Wilkinson, L.S. Smit, R.T. Worrell, T.V. Strong, R.A. Frizzell, D.C. Dawson and F.S. Collins (1991) Chloride conductance expressed by DF508 and other mutant CFTRs in Xenopus oocytes. Science 254 1797-1799.
56. F. Duffieux, J.P. Annereau, J. Boucher, E. Miclet, O. Pamlard, M. Schneider, V. Stoven and J.Y. Lallemand (2000) Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies. Eur. J. Biochem. 267(17), 5306-5312.
57. A.M. Dulhanty and J.R. Riordan (1994) Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry 33(13), 4072-4079.
58. R. Dutzler, E.B. Campbell, M. Cadene, B.T. Chait and R. MacKinnon (2002) X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415(6869), 287-294.
59. G. Eisenman and R. Horn (1983) Ionic selectivity revisited: the role of kinetic and equilibrium processes in ion permeation through channels. J. Membr. Biol. 76(3), 197-225.
60. S. Eskandari, E.M. Wright, M. Kreman, D.M. Starace and G.A. Zampighi (1998) Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy. Proc. Natl. Acad. Sci. USA 95(19), 11235-11240.
61. J.Q. Fan, S. Ishii, N. Asano and Y. Suzuki (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5(1), 112-115.
62. B.A. Foster, H.A. Coffey, M.J. Morin and F. Rastinejad (1999) Pharmacological rescue of mutant p53 conformation and function. Science 286(5449), 2507-2510.
63. R.A. Frizzell, G. Rechkemmer and R.L. Shoemaker (1986) Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 233 558-560.
64. S.E. Gabriel, L.L. Clarke, R.C. Boucher and M.J. Stutts (1993) CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature 363 263-268.
65. S.E. Gabriel, K.N. Brigman, B.H. Koller, R.C. Boucher and M.J. Stutts (1994) Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266(5282), 107-109.
66. D.C. Gadsby and A.C. Nairn (1999) Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol. Rev. 79(1 Suppl.), S77-S107.
67. D.C. Gadsby and A.C. Nairn (1999) Regulation of CFTR Cl− ion channels by phosphorylation and dephosphorylation. Adv. Sec. Mess. Phosph. 33 79-106.
68. L.J. Galietta, M.F. Springsteel, M. Eda, E.J. Niedzinski, K. By, M.J. Haddadin, M.J. Kurth, M.H. Nantz and A.S. Verkman (2001) Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquino-lizinium lead compounds. J. Biol. Chem. 276(23), 19723-19728.
69. M. Gao, H.R. Cui, D.W. Loe, C.E. Grant, K.C. Almquist, S.P. Cole and R.G. Deeley (2000) Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J. Biol. Chem. 275(17), 13098-13108.
70. H. Garty and L.G. Palmer (1997) Epithelial sodium channels: function, structure, and regulation. Physiol. Rev. 77(2), 359-396.
71. M.S. Gelman, E.S. Kannegaard and R.R. Kopito (2002) A principal role for the proteasome in ER-associated degradation of misfolded intracellular CFTR. J. Biol. Chem. 277 11709-11714.
72. M. Gentzsch and J.R. Riordan (2001) Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability. J. Biol. Chem. 276(2), 1291-1298.
73. M. Gentzsch, A. Aleksandrov, L. Aleksandrov and J.R. Riordan (2002) Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications. Biochem. J. 05/20/02 DOI: 10.1042/BJ20020511
74. M.A. Gray, J.R. Greenwell and B.E. Argent (1988) Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J. Mem. Biol. 105(2), 131-142.
75. M.A. Gray, A. Harris, L. Coleman, J.R. Greenwell and B.E. Argent (1989) Two types of chloride channel on duct cells cultured from human fetal pancreas. Am. J. Physiol. 257 C240-C251.
76. M.A. Gray, C.E. Pollard, A. Harris, L. Coleman, J.R. Greenwell and B.E. Argent (1990) Anion selectivity and block of the small-conductance chloride channel on pancreatic duct cells. Am. J. Physiol. 259(5), C752-C761. Pt 1
77. R. Guinamard and M.H. Akabas (1999) Arg352 is a major determinant of charge selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel. Biochemistry 38(17), 5528-5537.
78. K.L. Gunderson and R.R. Kopito (1994) Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. J. Biol. Chem. 269(30), 19349-19353.
79. J. Gupta, A. Evagelidis, J.W. Hanrahan and P. Linsdell (2001) Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region. Biochemistry 40(22), 6620-6627.
80. K.R. Hallows, V. Raghuram, B.E. Kemp, L.A. Witters and J.K. Foskett (2000) Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J. Clin. Invest. 105(12), 1711-1721.
81. M.M. Hämmerle, A.A. Aleksandrov and J.R. Riordan (2001) Disease-associated mutations in the extracytoplasmic loops of cystic fibrosis transmembrane conductance regulator do not impede biosynthetic processing but impair chloride channel stability. J. Biol. Chem. 276(18), 14848-14854.
82. J.W. Hanrahan, J.A. Tabcharani and R. Grygorczyk (1993) Patch clamp studies of apical membrane chloride channels. J.A. Dodge, D.J.H. Brock, J.H. Widdicombe (Eds) Cystic Fibrosis-Current Topics London: John Wiley and Sons 93-137.
83. J. Hartman, Z. Huong, T.A. Rado, S. Peng, T. Jilling, D.D. Muccio and E.J. Sorscher (1992) Recombinant synthesis purification and nucleotide binding characteristics of the first nucleotide binding domains of the cystic fibrosis gene product. J. Biol. Chem. 267 6455-6458.
84. C.F. Higgins (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8 67-113.
85. B. Hille (1992) Ionic Channels of Excitable Membranes Sunderland, MA: Sinauer Associates
86. M. Holmgren, Y. Liu, Y. Xu and G. Yellen (1996) On the use of thiol-modifying agents to determine channel topology. Neuropharmacology 35(7), 797-804.
87. K.P. Hopfner, A. Karcher, D.S. Shin, L. Craig, L.M. Arthur, J.P. Carney and J.A. Tainer (2000) Structural biology of Rad50 ATPase: ATP-driven conformation control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101(7), 789-800.
88. Y.-X. Hou, L. Cui, J.R. Riordan and X.-B. Chang (2000) Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J. Biol. Chem. 275 20280-20287.
89. L.D. Howell, R. Borchardt and J.A. Cohn (2000) ATP hydrolysis by a CFTR domain: pharmacology and effects of G551D mutation. Biochem. Biophys. Res. Commun. 271(2), 518-525.
90. P. Huang, E.R. Lazarowski, R. Tarran, S.L. Milgram, R.C. Boucher and M.J. Stutts (2001) Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc. Natl Acad. Sci. USA 98(24), 14120-14125.
91. T. Hwang, L. Lu, P.L. Zeitlin, D.C. Gruenert, R. Huganir and W.B. Guggino (1989) Cl− channels in CF: Lack of activation by protein kinase C and cAMP-dependent protein kinase. Science 244 1351-1353.
92. T.-C. Hwang, G. Baukrowtiz, G. Nagel, A.C. Horie and D.C. Gadsby (1994) Regulation of gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis. Proc. Natl Acad. Sci. USA 91 4698-4702.
93. M. Ikuma and M.J. Welsh (2000) Regulation of CFTR Cl− channel gating by ATP binding and hydrolysis. Proc. Natl Acad. Sci. USA 97(15), 8675-8680.
94. N. Inagaki, T. Gonoi, J.P. Clement, C.Z. Wang, L. Aguilar-Bryan, J. Bryan and S. Seino (1996) A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16(5), 1011-1017.
95. H. Ishihara and M.J. Welsh (1997) Block by MOPS reveals a conformation change in the CFTR pore produced by ATP hydrolysis. Am. J. Physiol. 273(4), C1278-C1289. Pt 1
96. T.J. Jensen, M.A. Loo, S. Pind, D.B. Williams, A.L. Goldberg and J.R. Riordan (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83 129-135.
97. Y. Jia, C.J. Mathews and J.W. Hanrahan (1997) Phosphorylation by protein kinase C is required for acute activation of cystic fibrosis transmembrane conductance regulator by protein kinase A. J. Biol. Chem. 272(8), 4978-4984.
98. N. Kalin, A. Claass, M. Sommer, E. Puchelle and B. Tummler (1999) DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis [see comments]. J. Clin. Invest. 103(10), 1379-1389.
99. N. Karpowich, O. Martsinkevich, L. Millen, Y.R. Yuan, P.L. Dai, K. MacVey, P.J. Thomas and J.F. Hunt (2001) Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure (Camb) 9(7), 571-586.
100. N. Kartner, J.W. Hanrahan, T.J. Jensen, A.L. Naismith, S. Sun, C.A. Ackerley, et al. (1991) Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 64(4), 681-691.
101. N. Kartner, O. Augustinas, T.J. Jensen, A.L. Naismith and J.R. Riordan (1992) Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat. Genet. 1(5), 321-327.
102. V. Keitel, J. Kartenbeck, A.T. Nies, H. Spring, M. Brom and D. Keppler (2000) Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 32(6), 1317-1328.
103. T. Klabunde, H.M. Petrassi, V.B. Oza, P. Raman, J.W. Kelly and J.C. Sacchettini (2000) Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 7(4), 312-321.
104. M.R. Knowles, M.J. Stutts, A. Spock, N. Fischer, J.T. Gatzy and R.C. Boucher (1983) Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221 1067-1070.
105. Y.H. Ko and P.L. Pedersen (1995) The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase. J. Biol. Chem. 270(38), 22093-22096.
106. Y.H. Ko, P.J. Thomas, M.R. Delannoy and P.L. Pedersen (1993) The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J. Biol. Chem. 268(32), 24330-24338.
107. I. Kogan, M. Ramjeesingh, L.J. Huan, Y. Wang and C.E. Bear (2001) Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its ATPase activity. J. Biol. Chem. 276(15), 11575-11581.
108. J. Konig, R. Schreiber, T. Voelcker, M. Mall and K. Kunzelmann (2001) The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl− concentration. EMBO Rep. 2(11), 1047-1051.
109. R.R. Kopito (1999) Biosynthesis and degradation of CFTR. Physiol. Rev. 79(1 Suppl.), S167-S173.
110. J.M. Kreda, M. Mall, H. Seydewitz, J. Kuehr, A. Mengos, T.J. Jensen, J.R. Riordan and R. Boucher (2001) CFTR expression in epithelia from cystic fibrosis patients. Mol. Biol. Cell (Suppl. 12), (Abstract 2137)
111. M.G. Lee, J.Y. Choi, X. Luo, E. Strickland, P.J. Thomas and S. Muallem (1999) Cystic fibrosis transmembrane conductance regulator regulates luminal Cl−/HCO3 − exchange in mouse submandibular and pancreatic ducts. J. Biol. Chem. 274(21), 14670-14677.
112. R.A. Lewis, N.F. Shroyer, N. Singh, R. Allikmets, A. Hutchinson, Y. Li, J.R. Lupski, M. Leppert and M. Dean (1999) Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am. J. Hum. Genet. 64(2), 422-434.
113. C. Li, M. Ramjeesingh, E. Reyes, T. Jensen, X. Chang, J.M. Rommens and C.E. Bear (1993) The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat. Genet. 3(4), 311-316.
114. C. Li, M. Ramjeesingh, W. Wang, E. Garami, M. Hewryk, D. Lee, J.M. Rommens, K. Galley and C.E. Bear (1996) ATPase activity of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271(45), 28463-28468.
115. M. Li, J.D. McCann, C.M. Liedtke, A.C. Nairn, P. Greengard and M.J. Welsh (1988) Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature 331 358-360.
116. P. Linsdell and J.W. Hanrahan (1996) Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl− channels expressed in a mammalian cell line and its regulation by a critical pore residue. J. Physiol. 496(Pt 3), 687-693.
117. P. Linsdell and J.W. Hanrahan (1998) Adenosine triphosphate-dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. J. Gen. Physiol. 111(4), 601-614.
118. P. Linsdell, J.A. Tabcharani, J.M. Rommens, Y.X. Hou, X.B. Chang, L.C. Tsui, J.R. Riordan and J.W. Hanrahan (1997) Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J. Gen. Physiol. 110(4), 355-364.
119. P. Linsdell, J.A. Tabcharani and J.W. Hanrahan (1997) Multi-ion mechanism for ion permeation and block in the cystic fibrosis transmembrane conductance regulator chloride channels. J. Gen. Physiol. 110(4), 365-377.
120. P. Linsdell, A. Evagelidis and J.W. Hanrahan (2000) Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore. Biophys. J. 78(6), 2973-2982.
121. M.A. Loo, T.J. Jensen, L. Cui, Y.-X. Hou, X.-B. chang and J.R. Riordan (1998) Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. 17 6879-6887.
122. T.W. Loo and D.M. Clarke (2000) Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J. Natl CancerInst. 92(11), 898-902.
123. G.L. Lukacs, A. Mohamed, N. Kartner, X.-B. Chang, J.R. Riordan and S. Grinstein (1994) Confirmational maturation of CFTR but not its mutant counterpart (DF508) occurs in the endoplasmic reticulum and requires. EMBO J. 13 6076-6086.
124. J. Luo, M.D. Pato, J.R. Riordan and J.W. Hanrahan (1998) Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases. Am. J. Physiol. 274(5), C1397-C1410. Pt 1
125. M.K. Mansoura, S.S. Smith, A.D. Choi, N.W. Richards, T.V. Strong, M.L. Drumm, F.S. Collins and D.C. Dawson (1998) Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys. J. 74(3), 1320-1332.
126. C.J. Mathews, J.A. Tabcharani and J.W. Hanrahan (1998) The CFTR chloride channel: nucleotide interactions and temperature-dependent gating. J. Membr. Biol. 163(1), 55-66.
127. H. Matsui, B.R. Grubb, R. Tarran, S.H. Randell, J.T. Gatzy, C.W. Davis and R.C. Boucher (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7), 1005-1015.
128. N.A. McCarty (2000) Permeation through the CFTR chloride channel. J. Exp. Biol. 203(Pt 13), 1947-1962.
129. S. McDonough, N. Davidson, H.A. Lester and N.A. McCarty (1994) Novel pore-lining residues in CFTR that govern permeation and open-channel block. Neuron 13(3), 623-634.
130. G.C. Meacham, Z. Lu, S. King, E. Sorscher, A. Tousson and D.M. Cyr (1999) The Hdj-2/Hsc 70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18 1492-1505.
131. G.C. Meacham, C. Patterson, W. Zhang, J.M. Younger and D.M. Cyr (2001) The Hsc70 co-chaperone CHIP targets immature CFTR for proteasonal degradation. Nat. Cell Biol. 3(1), 100-105.
132. L.M. Middleton and R.D. Harvey (1998) PKC regulation of cardiac CFTR Cl− channel function in guinea pig ventricular myocytes. Am. J. Physiol. 275(1), C293-C302. Pt 1
133. M.I. Milewski, J.E. Mickle, J.K. Forrest, D.M. Stafford, B.D. Moyer, J. Cheng, W.B. Guggino, B.A. Stanton and G.R. Cutting (2001) A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. J. Cell Sci. 114(Pt 4), 719-726.
134. M.M. Morales, T.P. Carroll, T. Morita, E.M. Schwiebert, O. Devuyst, P.D. Wilson, et al. (1996) Both the wild type and a functional isoform of CFTR are expressed in kidney. Am. J. Physiol. 270(6), F1038-F1048. Pt 2
135. J.P. Morello, A. Salahpour, A. Laperriere, V. Bernier, M.F. Arthus, M. Lonergan, et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105(7), 887-895.
136. K. Nagata, M. Nishitani, M. Matsuo, N. Kioka, T. Amachi and K. Ueda (2000) Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. J. Biol. Chem. 275(23), 17626-17630.
137. G. Nagel (1999) Differential function of the two nucleotide binding domains on cystic fibrosis transmembrane conductance regulator. Biochim. Biophys. Acta 1461(2), 263-274.
138. G. Nagel, T. Szellas, J.R. Riordan, T. Friedrich and K. Hartung (2001) Non-specific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep. 2(3), 249-254.
139. A.C. Nairn, J. Qin, B.T. Chait and D.C. Gadsby (1996) Identification of sites in the R-domain of CFTR phosphorylated by cAMP-dependent protein kinase and dephosphorylated by protein phosphatases 2A and 2C. Pediatr. Pulm. (Suppl. 13), 211. (Abstract)
140. A.P. Naren, D.J. Nelson, W. Xie, B. Jovov, J. Pevsner, M.K. Bennett, D.J. Benos, M.W. Quick and K.L. Kirk (1997) Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 390(6657), 302-305.
141. A.P. Naren, M.W. Quick, J.F. Collawn, D.J. Nelson and K.L. Kirk (1998) Syntaxin 1A inhibits CFTR chloride channels by means of domain-specific protein-protein interactions. Proc. Natl Acad. Sci. USA 95(18), 10972-10977.
142. A.P. Naren, E. Cormet-Boyaka, J. Fu, M. Villain, J.E. Blalock, M.W. Quick and K.L. Kirk (1999) CFTR chloride channel regulation by a interdomain interaction. Science 286(5439), 544-548.
143. D.J. Nelson, et al. (2001) CFTR associates with the P11 subunit of the annexin II heterotetramer. Pediatr. Pulm. (Suppl. 18), 178. (abstract)
144. D.C. Neville, C.R. Rozanas, E.M. Price, D.B. Gruis, A.S. Verkman and R.R. Townsend (1997) Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 6(11), 2436-2445.
145. D.C. Neville, C.R. Rozanas, B.M. Tulk, R.R. Townsend and A.S. Verkman (1998) Expression and characterization of the NBD1-R domain region of CFTR: evidence for subunit-subunit interactions. Biochemistry 37(8), 2401-2409.
146. N. Nishimura, S. Bannykh, S. Slabough, J. Matteson, Y. Altschuler, K. Hahn and W.E. Balch (1999) A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum. J. Biol. Chem. 274(22), 15937-15946.
147. P.G. Noone and M.R. Knowles (2001) CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir. Res. 2(6), 328-332.
148. C.M. O'Reilly, J.P. Winpenny, B.E. Argent and M.A. Gray (2000) Cystic fibrosis transmembrane conductance regulator currents in guinea pig pancreatic duct cells: inhibition by bicarbonate ions. Gastroenterology 118(6), 1187-1196.
149. L.R. Osborne, M. Lynch, P.G. Middleton, E.W. Alton, D.M. Geddes, J.P. Pryor, M.E. Hodson and G.K. Santis (1993) Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum. Mol. Genet. 2(10), 1605-1609.
150. L.S. Ostedgaard, O. Baldursson and M.J. Welsh (2001) Regulation of the cystic fibrosis transmembrane conductance regulator Cl− channel by its R domain. J. Biol. Chem. 276(11), 7689-7692.
151. M.R. Picciotto, J.A. Cohn, G. Bertuzzi, P. Greengard and A.C. Nairn (1992) Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 267 12742-12752.
152. P.F. Pignatti, C. Bombieri, M. Benetazzo, A. Casartelli, E. Trabetti, L.S. Gile, L.C. Martinati, A.L. Boner and M. Luisetti (1996) CFTR gene variant IVS8-5T in disseminated bronchiectasis. Am. J. Hum. Genet. 58(4), 889-892.
153. S. Pind, J.R. Riordan and D.B. Williams (1994) Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269(12), 12784-12788.
154. J.H. Poulsen, H. Fischer, B. Illek and T.E. Machen (1994) Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc. Natl Acad. Sci. USA 91(12), 5340-5344.
155. M.P. Price, H. Ishihara, D.N. Sheppard and M.J. Welsh (1996) Function of Xenopus cystic fibrosis transmembrane conductance regulator (CFTR) CI channels and use of human-Xenopus chimeras to investigate the pore properties of CFTR. J. Biol. Chem. 271(41), 25184-25191.
156. B.H. Qu and P.J. Thomas (1996) Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271(13), 7261-7264.
157. P.M. Quinton (1983) Chloride impermeability in cystic fibrosis. Nature 301 421-422.
158. P.M. Quinton (2001) The neglected ion: HCO3. Nat. Med. 7(3), 292-293.
159. P.M. Quinton and J. Bijman (1983) Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N. Engl. J. Med. 308 1185-1189.
160. P.M. Quinton and M.M. Reddy (1992) Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature 360(6399), 79-81.
161. V. Raghuram, D.D. Mak and J.K. Foskett (2001) Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. Proc. Natl Acad. Sci. USA 98(3), 1300-1305.
162. M. Ramjeesingh, C. Li, E. Garami, L.J. Huan, K. Galley, Y. Wang and C.E. Bear (1999) Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator). Biochemistry 38(5), 1463-1468.
163. M. Ramjeesingh, C. Li, I. Kogan, Y. Wang, L.J. Huan and C.E. Bear (2001) A monomer is the minimum functional unit required for channel and ATPase activity of the cystic fibrosis transmembrane conductance regulator. Biochemistry 40(35), 10700-10706.
164. C. Randak, A.A. Roscher, H.B. Hadorn, I. Assfalg-Machleidt, E.A. Auerswald and W. Machleidt (1995) Expression and functional properties of the second predicted nucleotide binding fold of CFTR fused to GST. FEBS Lett. 363 189-194.
165. C. Randak, P. Neth, E.A. Auerswald, I. Assfalg-Machleidt, A.A. Roscher, H.B. Hadorn and W. Machleidt (1996) A recombinant polypeptide model of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator is a GTP-binding protein. FEBS Lett. 398(1), 97-100.
166. C. Randak, P. Neth, E.A. Auerswald, C. Eckerskorn, I. Assfalg-Machleidt and W. Machleidt (1997) A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase. FEBS Lett. 410(2–3), 180-186.
167. M.M. Reddy, M.J. Light and P.M. Quinton (1999) Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl− channel function. Nature 402(6759), 301-304.
168. J.R. Riordan (1999) Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. Am. J. Hum. Genet. 64(6), 1499-1504.
169. J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922), 1066-1073.
170. C. Ritter and A. Helenius (2000) Recognition of local glycoprotein misfolding by the ER folding sensor UDP-glucose:glycoprotein glucosyltransferase. Nat. Struct. Biol. 7(4), 278-280.
171. M.F. Rosenberg, R. Callaghan, R.C. Ford and C.F. Higgins (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272(16), 10685-10694.
172. M.F. Rosenberg, Q. Mao, A. Holzenburg, R.C. Ford, R.G. Deeley and S.P. Cole (2001) The structure of the multidrug resistance protein 1 (MRP1/ABCC1) crystallization and single-particle analysis. J. Biol. Chem. 276(19), 16076-16082.
173. R.C. Rubenstein and P.L. Zeitlin (2000) Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of Delta F508-CFTR. Am. J. Physiol. Cell Physiol. 278(2), C259-C267.
174. S. Sato, C.L. Ward and R.R. Kopito (1998) Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro. J. Biol. Chem. 273(13), 7189-7192.
175. W. Saurin, M. Hofnung and E. Dassa (1999) Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J. Mol. Evol. 48(1), 22-41.
176. R.A. Schoumacher, R.L. Shoemaker, D.R. Halm, E.A. Tallant, R.W. Wallace and R.A. Frizzell (1987) Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells. Nature 330 752-754.
177. B.D. Schultz, R.J. Bridges and R.A. Frizzell (1996) Lack of conventional ATPase properties in CFTR chloride channel gating. J. Membr. Biol. 151(1), 63-75.
178. B.D. Schultz, A.K. Singh, D.C. Devor and R.J. Bridges (1999) Pharmacology of CFTR chloride channel activity. Physiol. Rev. 79(1 Suppl.), S109-S144.
179. E.M. Schweibert, D.J. Benos, M.E. Egan, M.J. Stutts and W.B. Guggino (1999) CFTR is a conductance regulator as well as a chloride channel. Physiol. Rev. 79 145.
180. F.S. Seibert, J.A. Tabcharani, X.-B. Chang, A.M. Dulhanty, C. Mathews, J.W. Hanrahan and J.R. Riordan (1995) cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue ser-753 and its role in channel activation. J. Biol. Chem. 270(5), 2158-2162.
181. F.S. Seibert, P. Linsdell, T.W. Loo, J.W. Hanrahan, D.M. Clarke and J.R. Riordan (1996) Disease-associated mutations in the fourth cytoplasmic loop of CFTR compromise biosynthetic processing and chloride channel activity. J. Biol. Chem. 271 15139-15143.
182. F.S. Seibert, P. Linsdell, T.W. Loo, J.W. Hanrahan, J.R. Riordan and D.M. Clarke (1996) Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J. Biol. Chem. 271(44), 27493-27499.
183. F.S. Seibert, Y. Jia, C.J. Mathews, J.W. Hanrahan, J.R. Riordan, T.W. Loo and D.M. Clarke (1997) Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry 36(39), 11966-11974.
184. A.E. Senior and D.C. Gadsby (1997) ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. Semin. Cancer Biol. 8(3), 143-150.
185. N. Sharer, M. Schwarz, G. Malone, A. Howarth, J. Painter, M. Super and J. Braganza (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N. Engl. J. Med. 339(10), 645-652.
186. D.N. Sheppard and M.J. Welsh (1999) Structure and function of the CFTR chloride channel. Physiol. Rev. 79(1 Suppl.), S23-S45.
187. D.N. Sheppard, D.P. Rich, L.S. Ostedgaard, R.J. Gregory, A.E. Smith and M.J. Welsh (1993) Mutations in CFTR associated with mild-disease-form Cl− channels with altered pore properties. Nature 362(6416), 160-164.
188. D.N. Sheppard, L.S. Ostedgaard, D.P. Rich and M.J. Welsh (1994) The amino-terminal portion of CFTR forms a regulated Cl− channel. Cell 76(6), 1091-1098.
189. D.B. Short, K.W. Trotter, D. Reczek, S.M. Kreda, A. Bretscher, R.C. Boucher, M.J. Stutts and S.L. Milgram (1998) An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273(31), 19797-19801.
190. J.J. Smith, S.M. Travis, E.P. Greenberg and M.J. Welsh (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85(2), 229-236. [published erratum appears in Cell 1996 Oct 18; 87(2), following 355]
191. K.D. Smith, S. Kemp, L.T. Braiterman, J.F. Lu, H.M. Wei, M. Geraghty, G. Stetten, J.S. Bergin, J. Pevsner and P.A. Watkins (1999) X-linked adrenoleukodystrophy: genes, mutations and phenotypes. Neurochem. Res. 24(4), 521-535.
192. S.S. Smith, X. Liu, Z.R. Zhang, F. Sun, T.E. Kriewall, N.A. McCarty and D.C. Dawson (2001) CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J. Gen. Physiol. 118(4), 407-431.
193. J. Sturgess and J. Imrie (1982) Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am. J. Pathol. 106(3), 303-311.
194. M.J. Stutts, C.M. Canessa, J.C. Olsen, M. Hamrick, J.A. Cohn, B.C. Rossier and R.C. Boucher (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 269 847-850.
195. K. Szabo, G. Szakacs, T. Hegeds and B. Sarkadi (1999) Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains. J. Biol. Chem. 274(18), 12209-12212.
196. J.A. Tabcharani, D. Low, D. Elie and J.W. Hanrahan (1990) Low conductance chloride channel activated by cAMP in the epithelial cell line T84. FEBS Lett. 270 157-164.
197. J.A. Tabcharani, X.-B. Chang, J.R. Riordan and J.W. Hanrahan (1991) Phosphorylation-regulated Cl− channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352 628-631.
198. J.A. Tabcharani, X.-B. Chang, J.R. Riordan and J.W. Hanrahan (1992) The cystic fibrosis transmembrane conductance regulator chloride channel: Iodide block and permeation. Biophys. J. 62 1-4.
199. J.A. Tabcharani, J.M. Rommens, Y.X. Hou, X.B. Chang, L.C. Tsui, J.R. Riordan and J.W. Hanrahan (1993) Multi-ion pore behaviour in the CFTR chloride channel. Nature 366(6450), 79-82.
200. A.G. Therien, F.E. Grant and C.M. Deber (2001) Interhelical hydrogen bonds in the CFTR membrane domain. Nat. Struct. Biol. 8(7), 597-601.
201. P.J. Thomas and J.F. Hunt (2001) A snapshot of Nature's favorite pump. Nat. Struct. Biol. 8(11), 920-923.
202. S.M. Travis, M.R. Carson, D.R. Ries and M.J. Welsh (1993) Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 268(21), 15336-15339.
203. S.M. Travis, H.A. Berger and M.J. Welsh (1997) Protein phosphatase 2C dephosphorylates and inactivates cystic fibrosis transmembrane conductance regulator. Proc. Natl Acad. Sci. USA 94(20), 11055-11060.
204. I.L. Urbatsch, B. Sankaran, J. Weber and A.E. Senior (1995) P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J. Biol. Chem. 270(33), 19383-19390.
205. S. Wang, H. Yue, R.B. Derin, W.B. Guggino and M. Li (2000) Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103(1), 169-179.
206. C.L. Ward, S. Omura and R.R. Kopito (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 121-127.
207. K.M. Weixel and N.A. Bradbury (2001) Mu 2 binding directs the cystic fibrosis transmembrane conductance regulator to the clathrin-mediated endocytic pathway. J. Biol. Chem. 276(49), 46251-46259.
208. M.J. Welsh, A.D. Robertson and L.S. Ostegaard (1998) Structural biology. The ABC of a versatile engine. Nature 396(6712), 623-624.
209. D.J. Wilkinson, T.V. Strong, M.K. Mansoura, D.L. Wood, S.S. Smith, F.S. Collins and D.C. Dawson (1997) CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am. J. Physiol. 273(1 Pt 1), L127-L133.
210. N.J. Willumsen and R.C. Boucher (1989) Shunt resistance and ion permeabilities in normal and cystic fibrosis airway epithelia. Am. J. Physiol. 256 C1054-C1063.
211. J. Yamazaki, F. Britton, M.L. Collier, B. Horowitz and J.R. Hume (1999) Regulation of recombinant cardiac cystic fibrosis transmembrane conductance regulator chloride channels by protein kinase C. Biophys. J. 76(4), 1972-1987.
212. N. Yang, A.L. George Jr. and R. Horn (1996) Molecular basis of charge movement in voltage-gated sodium channels. Neuron 16(1), 113-122.
213. Y. Yang, S. Janich, J.A. Cohn and J.M. Wilson (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl Acad. Sci. USA 90 9480-9484.
214. J.-S. Yoo, B.D. Moyer, S.I. Bannykh, H.-M. Yoo, J.R. Riordan and W.E. Balch (2002) Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) through the early secretory pathway. J. Biol. Chem. 277 1140-1149.
215. H. Yue, S. Devidas and W.B. Guggino (2000) The two halves of CFTR form a dual-pore ion channel. J. Biol. Chem. 275(14), 10030-10034.
216. P.L. Zeitlin (2000) Pharmacologic restoration of delta F508 CFTR-mediated chloride current. Kidney Int. 57(3), 832-837.
217. N. Zerangue, B. Schwappach, Y.N. Jan and L.Y. Jan (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels. Neuron 22 537-548.
218. B. Zerhusen, J. Xie, P.B. Davis and J. Ma (1999) A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. J. Biol. Chem. 274(12), 7627-7630.
219. Z.R. Zhang, S.I. McDonough and N.A. McCarty (2000) Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator. Biophys. J. 79(1), 298-313.
220. T. Zhu, D. Dahan, A. Evagelidis, S. Zheng, J. Luo and J.W. Hanrahan (1999) Association of cystic fibrosis transmembrane conductance regulator and protein phosphatase 2C. J. Biol. Chem. 274(41), 29102-29107.
221. X. Zou and T.C. Hwang (2001) ATP hydrolysis-coupled gating of CFTR chloride channels: structure and function. Biochemistry 40(19), 5579-5586.